Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fierce Pharma Asia
Pharma
China biotech deals, Takeda, LaNova—Fierce Pharma Asia
Biotech deals originating out of China are surging. Takeda touts a pair of OX2R phase 3 wins. Merck's PD-1xVEGF partner is being acquired. And more.
Angus Liu
Jul 18, 2025 9:04am
Lilly-Innovent, Dizal, bispecific ADC—Fierce Pharma Asia
Jul 10, 2025 5:20pm
RemeGen, Harbour, Datroway—Fierce Pharma Asia
Jun 27, 2025 8:37am
AstraZeneca-CSPC, FDA, NMPA—Fierce Pharma Asia
Jun 20, 2025 11:28am
Pfizer CEO, Otsuka, Novartis-MSN—Fierce Pharma Asia
Jun 13, 2025 9:18am
PD-1 bispecifics, Enhertu, Regeneron-Hansoh—Fierce Pharma Asia
Jun 6, 2025 7:15am
